Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

November is National Diabetes month, and it’s a great time to raise awareness about diabetes and to learn how to prevent or delay Type 2 diabetes, especially if it runs in your family. Well, let me ...

Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilin™), fast-acting aspart ...

Since the start of 2024, Wockhardt’s stock price has almost tripled to Rs 1,233.85 per share as on November 8.

Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

Tirzepatide demonstrates greater efficacy than long-acting and ultra-long-acting insulin for managing type 2 diabetes, yielding greater improvements in glycemic control, weight loss, and ...

Until the advent of lente insulin the preparation of insulins ... In the preparation of these long-acting insulins a phosphate buffer has commonly been used. Under these conditions, the use ...